Developing User-Facing Components of a Research-Grade, MRI-Bolt on Technology Toward the Clinic to Enable Routine Functional Imaging Free of Any Radiation
NCBiotech Grants & Loans
See the full listing of all NCBiotech grants and loans awarded since July 2012.
Vizma Life Sciences is developing an automated benchtop hyperpolarization instrument and its first accompanying hyperpolarized injectable agent, pyruvate, that will enable existing magnetic resonance imaging scanners (MRI) to also image metabolic function. The company has received a$ 250,000 SRL to fund development of the hyperpolarized injectable contrast agent signal into a readable MRI image.